Octreotide-d8 (acetate)
Octreotide-d8 (acetate) (SMS 201-995-d8 (acetate) ) is deuterium labeled Octreotide. Octreotide (SMS 201-995) is a somatostatin receptor agonist and synthetic octapeptide endogenous somatostatin analogue. Octreotide (SMS 201-995) can bind to the somatostatin receptor and mainly subtypes 2, 3, and 5, increases Gi activity, and reduces intracellular cAMP production. Octreotide (SMS 201-995) has antitumor activity, mediates apoptosis and may also be used in disease studies in acromegaly[1][2].
Product Specifications
Product Name Alternative
SMS 201-995-d8 (acetate)
UNSPSC
12352211
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Endocrinology; Inflammation/Immunology; Cardiovascular Disease
Smiles
Molecular Formula
C51H62D8N10O12S2
Molecular Weight
1087.34
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD44 Standard (DF1485), CF488A conjugate, 0.1mg/mL
CD45RO (UCHL-1), CF405S conjugate, 0.1mg/mL
Major Vault Protein (MVP) (1032), CF647 conjugate, 0.1mg/mL
